Reetta Kälviäinen

Arzimanoglou, Alexis; Brandl, Ulrich; Cross, Helen J; Gil-Nagel, Antonio; Lagae, Lieven; Johannessen Landmark, Cecilie ; Specchio, Nicola; Nabbout, Rima; Thiele, Elizabeth A; Gubbay, Oliver; Auvin, Stéphane; Carreño, Mar; Chin, Richard; Cilio, Roberta; Di Marzo, Vincenzo; Del Carmen Fons-Estupina, Maria; Hughes, Elaine; Jansen, Floor E; Kälviäinen, Reetta; Lerman-Sagie, Tally et al.. 2020. Epilepsy and cannabidiol: a guide to treatment Epileptic disorders 22 1: 1-14. 2020

Rosenow, Felix; Brandt, Christian; Bozorg, Ali; Dimova, Svetlana; Steiniger-Brach, Björn; Zhang, Ying; Ferrò, Bruno; Holmes, Gregory; Kälviäinen, Reetta. 2020. Lacosamide in Patients With Epilepsy of Cerebrovascular Etiology Acta neurologica scandinavica 141 6: 473-482. 2020

Sisodiya, Sanjay M; Whelan, Christopher D; Hatton, Sean N; Huynh, Khoa; Altmann, Andre; Ryten, Mina; Vezzani, Annamaria; Caligiuri, Maria Eugenia; Labate, Angelo; Gambardella, Antonio; Ives-Deliperi, Victoria; Meletti, Stefano; Munsell, Brent C; Bonilha, Leonardo; Tondelli, Manuela; Rebsamen, Michael; Rummel, Christian; Vaudano, Anna Elisabetta; Wiest, Roland; Balachandra, Akshara R et al. incl. K. 2020. The ENIGMA-Epilepsy working group: Mapping disease from large data sets Human brain mapping [Online ahead of print]: 1-16. 2020

Sairanen, JJ; Kantanen, AM; Hyppölä, HT; Kälviäinen, RK. 2020. Outcome of status epilepticus and the predictive value of the EMSE and STESS scores: A prospective study Seizure: european journal of epilepsy 75: 115-120. 2020

Hyppönen, J; Hakala, A; Annala, K; Zhang, H; Peltola, J; Mervaala, E; Kälviäinen, R. 2020. Automatic assessment of the myoclonus severity from videos recorded according to standardized Unified Myoclonus Rating Scale protocol and using human pose and body movement analysis Seizure: european journal of epilepsy 76: 72-78. 2020

Raatikainen, M; Kälviäinen, R; Jutila, L; Äikiä, M. 2020. Cognitive functioning in new-onset juvenile myoclonic epilepsy Epilepsy and behavior 106: 107015. 2020

Progressive Myoclonic Epilepsy Type 1: 2004 Jun 24 [Updated 2020 Jul 2]. Lehesjoki, Anna-Elina; Kälviäinen, Reetta / GeneReviews® [Internet]. 2020. 2020

Niestroj, Lisa-Marie; Perez-Palma, Eduardo; Howrigan, Daniel P; Zhou, Yadi; Cheng, Feixiong; Saarentaus, Elmo; Nürnberg, Peter; Stevelink, Remi; Daly, Mark J; Palotie, Aarno; Lal, Dennis; Berkovic, Samuel F; Scheffer, Ingrid E; Regan, Brigid M; Bennett, Caitlin A; Bellows, Susannah T; Johns, Esther MC; Macdonald, Alexandra; Shilling, Hannah; Burgess, Rosemary (incl. Kälviäinen, Reetta; Auvinen, Pi. 2020. Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects Brain 143 7: 2106-2118. 2020

Kälviäinen, Reetta. 2020. Lääkkeiden saatavuushäiriöt ovat lisääntyneet merkittävästi EPILEPSIA-LEHTI 51 1: 17-18. 2020

Kälviäinen, Reetta; Reinikainen, Matti. 2019. Management of prolonged epileptic seizures and status epilepticus in palliative care patients Epilepsy and behavior 101 Part B: 106288. 2019

Zelano, Johan; Klecki, Judith; Christensen, Jakob; Tomson, Torbjörn; Malmgren, Kristina; The ESBACE consortium Collaborators (incl. Kälviäinen, Reetta). 2019. The provision of epilepsy care across Europe 2017: A 17-year follow-up survey Epilepsia open 4 1: 144-152. 2019

Väätäinen, S; Soini, E; Peltola, J; Charokopou, M; Taiha, M; Kälviäinen, R. 2019. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland Advances in therapy 2020; 37 1: 477-500. 2019

Tomson, Torbjörn; Battino, Dina; Bonizzon,i Erminio; Craig, John; Lindhout, Dick; Perucca, Emilio; Sabers, Anne; Thomas, Sanjeev V; Vajda Frank; for The EURAP Study Group [incl. Kälviäinen, R]. 2019. Declining malformation rates with changed antiepileptic drug prescribing: An observational study Neurology 93 9: e831-e840. 2019

Strzelczyk, A; Knake, S; Kälviäinen, R; Santamarina, E; Toledo, M; Willig, S; Rohracher, A; Trinka, E; Rosenow, F. 2019. Perampanel for treatment of status epilepticus in Austria, Finland, Germany and Spain Acta neurologica scandinavica 139 4: 369-376. 2019

Sairanen, JJ; Kantanen, AM; Hyppölä, HT; Kälviäinen, RK. 2019. Treatment delay in status epilepticus - more effective prehospital symptom recognition warranted Scandinavian journal of trauma, resuscitation and emergency medicine 27: 28. 2019

Leu, Costin; Stevelink, Remi; Smith, Alexander W; Goleva, Slavina B; Kanai, Masahiro; Ferguson, Lisa; Campbell, Ciaran; Kamatani, Yoichiro; Okada, Yukinori; Sisodiya, Sanjay M; Cavalleri, Gianpiero L; Koeleman, Bobby PC; Lerche, Holger; Jehi, Lara; Davis, Lea K; Najm, Imad M; Palotie, Aarno; Epi25 Consortium; (incl. Kälviäinen, Reetta; Auvinen, Pia; Saarela, Anni). 2019. Polygenic burden in focal and generalized epilepsies Brain 142 11: 3473-3481. 2019

Kälviäinen, Reetta. 2019. Epielpsian Käypä hoito -suositukset on päivitetty EPILEPSIA-LEHTI 50 5: 9-10. 2019

Kälviäinen, Reetta. 2019. Epilepsian hoidon kehitys EPILEPSIA-LEHTI 50 4: 5-6. 2019

Kantanen, Anne-Mari; Sairanen, Joi; Kälviäinen, Reetta. 2019. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study Epilepsy and behavior 101 Part B: 106413. 2019

George, Allan; Kuzniecky, Ruben; Rusinek, Henry; Pardoe, Heath R.; French, Jacqueline; Lowenstein, Daniel; Cristofaro, Sabrina; McKenna, Kevin; Mays, Vickie; Shack, Darrell; Barnard, Sarah; Burke, Cheryl; Hegde, Manu; Glauser, Tracy; O'Brien, Terence; Pollard, John; Ting, Tricia; Meador, Kimford; Darby, David; Morrison, Chris et al (Incl Kälviäinen, Reetta). 2019. Standardized Brain MRI Acquisition Protocols Improve StatisticalPower in Multicenter Quantitative Morphometry Studies Journal of neuroimaging 2020; 30 1: 126-133. 2019

Reijula, Emmi; Halkoaho, Arja; Pietilä, Anna-Maija; Selander, Tuomas; Martikainen, Kirsti; Kälviäinen, Reetta; Keränen, Tapani. 2018. Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants. SEIZURE 60: 61-67. 2018

Whelan, CD; Altmann, A; Botía, JA; Jahanshad, N; Hibar, DP; Absil, J; Alhusaini, S; Alvim, MKM; Auvinen, P; Bartolini, E; Bergo, FPG; Bernardes, T; Blackmon, K; Braga, B; Caligiuri, ME; Calvo, A; Carr, SJ; Chen, J; Chen, S; Cherubini, A; et al [Incl. Kälviäinen, R]. 2018. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study BRAIN [ONLINE] 141 2: 391-408. 2018

Virta, LJ; Kälviäinen, R; Villikka, K; Keränen, T. 2018. Declining trend in valproate use in Finland among childbearing-aged females in 2012-2016 - a nationwide registry-based outpatient study. EUROPEAN JOURNAL OF NEUROLOGY 25 6: 869-874. 2018

Tomson, T; Battino, D; Bonizzoni, E; Craig, J; Lindhout, D; Perucca, E; Sabers, A; Thomas, SV; Vajda, F; Faravelli, F; Pantaleoni, C; Robert-Gnansia, E; Cabral-Lim, L; Cebular, B; De Marinis, A; Kälviäinen, R; Khomeriki, K; Kiteva-Trencevska, G; Kochen, S; EURAP Study Group; et al.(incl. Kälviäinen Reetta). 2018. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry The Lancet Neurology 17 6: 530-538. 2018

The International League Against Epilepsy Consortium on Complex Epilepsies; [Incl. Kälviäinen, Reetta]. 2018. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies Nature Communications 9: 5269. 2018

Shorvon, SD; Bermejo, PE; Gibbs, AA; Huberfeld, G; Kälviäinen, R. 2018. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. EPILEPSY & BEHAVIOR 82: 91-103. 2018

Hynynen, J; Pokka, T; Komulainen-Ebrahim, J; Myllynen, P; Kärppä, M; Pylvänen, L; Kälviäinen, R; Sokka, A; Jyrkilä, A; Lähdetie, J; Haataja, L; Mäkitalo, A; Ylikotila, P; Eriksson, K; Haapala, P; Ansakorpi, H; Hinttala, R; Vieira, P; Majamaa, K; Rantala, H; et al. 2018. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy Epilepsia 59 11: 2125-2136. 2018

Kälviäinen, Reetta; Straus, Sabine; Dogne, Jean-Michel; Bakchine, Serge; Haas, Manuel. 2018. Reducing valproate use in women with epilepsy The Lancet Neurology 17 7: 580-581. 2018

Julkunen, Petro; Löfberg, Olli; Kallioniemi, Elisa; Hyppönen, Jelena; Kälviäinen, Reetta; Mervaala, Esa. 2018. Abnormal motor cortical adaptation to external stimulus in Unverricht-Lundborg disease (progressive myoclonus type 1, EPM1) JOURNAL OF NEUROPHYSIOLOGY 120 2: 617-623. 2018

Anttila, V; Bulik-Sullivan, B; Finucane, HK; Walters, RK; Bras, J; Duncan, L; Escott-Price, V; Falcone, GJ; Gormley, P; Malik, R; Patsopoulos, NA; Ripke, S; Wei, Z; Yu, D; Lee, PH; Turley, P; Grenier-Boley, B; Chouraki, V; Kamatani, Y; Berr, C; et al [Incl Kälviäinen, Reetta]. 2018. Analysis of shared heritability in common disorders of the brain Science 360 6395: eaap8757. 2018

Helmstaedter, Christoph; Beghi, Ettore; Elger, Christian E; Kälviäinen, Reetta; Malmgren, Kristina; May, Theodor W; Perucca, Emilio; Trinka, Euden; Witt, Juri-Alexander. 2018. No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk - An analysis of Finnish health register and German health insurance data Epilepsia 59 7: 1303-1306. 2018

Helmstaedter, Christoph; Beghi, Ettore; Elger, Christian E; Kälviäinen, Reetta; Malmgren, Kristina; May, Theodor W; Perucca, Emilio; Trinka, Euden; Witt, Juri-Alexander. 2018. No Evidence of a Causal Role of Antiepileptic Drug Treatment with Regard to the Development of Dementia Journal of the american geriatrics society 66 9: 1850-1852. 2018

Ferlisi, M; Hocker, S; Trinka, E; Shorvon, S; International Steering Committee of the StEp Audit (incl. Singh, G; Kälviäinen, R; Kramer, U; Godoy, D; Newton, C; O'Brien, T; Cook, M; Rossetti, A; Groppa, S; Kumlien, E; Ercegovac, M; Yasiry, Z; Guecht, A; Wu, T; Nabbout, R; Tripathi, M; et al.). 2018. Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit Epilepsia 59 S2: 100-107. 2018

Baud, Maxime O; Perneger, Thomas; Racz, Attila; Pensel, Max C; Elger, Christian; Rydenhag, Bertil; Malmgren, Kristina; Cross, J Helen; McKenna, Grainne; Tisdall, Martin; Lamberink, Herm J; Rheims, Sylvain; Ryvlin, Philippe; Isnard, Jean; Mauguiere, Francois; Arzimanoglou, Alexis; Akkol, Serdar; Deniz, Kaancan; Ozkara, Cigdem; Lossius, Morten et al. [Incl Kälviäinen, Reetta]. 2018. European trends in epilepsy surgery NEUROLOGY 91 2: E96-E106. 2018

Vogt VL, Äikiä M, del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E et al. 2017. Current standards of neuropsychological assessment in epilepsy surgery centers across Europe. EPILEPSIA (NY) 58 3: 343-355. 2017

The value of treatment for brain disorders. Quoidbach V, Esposito G, Destrebecq F, Kramer S, Tinelli M, Knapp M, Guldemond N, Dodel R, Gaebel W, Kälviäinen R, Kehler U, Mitsikostas D, Sørensen PS, Trenkwalder C, Vanhooren G, Visser PJ. 2017 2017

Sokka Arja, Olsen Päivi, Kirjavainen Jarkko, Harju Maijakaisa, Keski-Nisula Leea, Räisänen Sari, Heinonen Seppo, Kälviäinen Reetta. 2017. Etiology, syndrome diagnosis, and cognition in childhood-onset epilepsy: A population-based study. Epilepsia Open 2 1: 76-83. 2017

Reuber Markus, Kälviänen Reetta. 2017. Seizure - European Journal of Epilepsy at age 25: Where are we now and where we are going?. SEIZURE 44: 1-3. 2017

Reijula E, Pietilä AM, Halkoaho A, Selander T, Martikainen K, Kälviäinen R, Keränen T. 2017. Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials. TRIALS [ONLINE] 18 1: 444. 2017

Rauramaa Tuomas, Solomon Alina, Pikkarainen Maria, Kälviäinen Reetta, Alafuzoff Irina. 2017. Hippocampal Sclerosis and Epilepsy in Elderly Population. Journal of Alzheimers Disease & Parkinsonism 7 5: 384. 2017

Marson AG, Bolan A, Mahon J, Little A, Dickson R, Boon P, Depondt C, Martikainen J, Ryvlin P, Kälviäinen R. 2017. Cost savings and improved patient outcomes from best management of epilepsy. Teoksessa: Nutt D, Boyer P, Di luca M, Oertel W (toim.) The value of treatment for brain disorders. EBC Research Project. s. 105-109. 2017

Kimiskidis Vasilios K, Tsimpiris Alkiviadis, Ryvlin Philippe, Kalviainen Reetta, Koutroumanidis Michalis, Valentin Antonio, Laskaris Nikolaos, Kugiumtzis Dimitris. 2017. TMS combined with EEG in Genetic Generalized Epilepsy: A phase II diagnostic accuracy study. CLINICAL NEUROPHYSIOLOGY 128 2: 367-381. 2017

Kantanen A-M, Reinikainen M, Parviainen I, Kälviäinen R. 2017. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. EPILEPSY RESEARCH 133: 13-21. 2017

Kantanen A-M, Kälviäinen R, Parviainen I, Ala-Peijari M, Bäcklund T, Koskenkari J, Laitio R, Reinikainen M. 2017. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study. CRITICAL CARE (ONLINE) 21 1: 1-7. 2017

Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frösen J, Koivisto T, von und zu Fraunberg M, Immonen A, Jääskeläinen JE, Kälviäinen R. 2017. Epilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage. NEUROLOGY 89 3: 263-268. 2017

Holtkamp Martin, Beghi Ettore, Benninger Felix, Kälviäinen Reetta, Rocamora Rodrigo, Christensen Hanne. 2017. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. European Stroke Journal 2 2: 103-115. 2017

Early Intervention : Bridging the Early Diagnosis and Treatment Gap - a policy white paper towards optimizing research and care for brain disorders. Mohr P, Ieven A, Arteel P, Winkler P, La Park A, Boyer P, Galderisi S, Karkkainen H, Wasserman D, Gaebel W,Jaarsma J, Dauvilliers Y, Ferri R, Rijsman R, Sakkas GK, Trenkwalder C, Oertel W, Ahmerkamp-Böhme J, Petersen G, Deuschl G, Michler F et al (incl. Kälviäinen R, Martikainen J). 2017 2017

Bruun Emmi, Virta Lauri J, Kälviäinen Reetta, Keränen Tapani. 2017. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy. EPILEPSY & BEHAVIOR 73: 71-76. 2017

Trinka Eugen, Kälviäinen Reetta. 2016. 25 years of advances in the definition, classification and treatment of status epilepticus. SEIZURE 2017; 44: 65-73. 2016

Reuber M, Helmstaedter C, Liao W, Loddenkemper T, Thomas R, Kälviäinen R, Mann M. 2016. The future of medicine will be dark without international collaboration. SEIZURE 41 42: 1. 2016

Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung et al, E-PILEPSY consortium (incl. Kälviäinen R). 2016. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. EPILEPSIA (NY) 57 5: 770-776. 2016

Michelucci Roberto, Pasini Elena, Riguzzi Patrizia, Andermann Eva, Kälviäinen Reetta, Genton Pierre. 2016. Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials. EPILEPTIC DISORDERS 18 S2: S145-S153. 2016

Kivekäs Eija, Kinnunen Ulla-Mari, Paananen Pekka, Kälviäinen Reetta, Haatainen Kaisa, Saranto Kaija. 2016. Functionality of Triggers for Epilepsy Patients Assessed by Text and Data Mining of Medical and Nursing Records. Teoksessa: Sermeus Walter, Procter Paula M, Weber Patrick (toim.) Nursing Informatics 2016. Ios press. Studies in Health Technology and InformaticsY 225. s. 128-132. 2016

Kinnunen Ulla-Mari, Kivekäs Eija, Paananen Pekka, Kälviäinen Reetta, Saranto Kaija. 2016. Testing of triggers by data mining of epilepsy patients' structured nursing records. Teoksessa: Walter Sermeus, Paula M. Procter, Patrick Weber (toim.) Nursing Informatics 2016. Ios press. Studies in Health Technology and Informatics 225. s. 461-465. 2016

Huttunen Jukka, Lindgren Antti, Kurki Mitja I, Huttunen Terhi, Frösen Juhana, von und zu Fraunberg Mikael, Koivisto Timo, Kälviäinen Reetta, Räikkönen Katri, Viinamäki Heimo, Jääskeläinen Juha E, Immonen Arto. 2016. Antidepressant Use After Aneurysmal Subarachnoid Hemorrhage: A Population-Based Case-Control Study. STROKE 47 9: 2242-8. 2016

Bruun Emmi, Kälviäinen Reetta, Keränen Tapani. 2016. Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy. EPILEPSY RESEARCH 127: 60-65. 2016

Crespel Arielle, Ferlazzo Edoardo, Franceschetti Silvana, Genton Pierre, Gouider Riadh, Kälviäinen Reetta, Korja Miikka, Lehtinen Maria K, Mervaala Esa, Simonato Michele, Vaarmann Annika. 2016. Unverricht-Lundborg disease. EPILEPTIC DISORDERS 18 Suppl. 2: S28-S37. 2016

Kobulashvili T, Höfler J, Dobesberger J, Ernst F, Ryvlin P, Cross JH, Braun K, Dimova P, Francione S, Hecimovic H, Helmstaedter C, Kimiskidis VK, Lossius MI, Malmgren K, Marusic P, Steinhoff BJ, Boon P, Craiu D, Delanty N, Fabo D et al. 2016. Current practices in long-term video-EEG monitoring services: A survey among partners of the E-PILEPSY pilot network of reference for refractory epilepsy and epilepsy surgery. SEIZURE 38: 38-45. 2016

Reijula Emmi, Halkoaho Arja, Pietilä Anna-Maija, Selander Tuomas, Kälviäinen Reetta, Keränen Tapani. 2015. Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling. EPILEPSY & BEHAVIOR 48: 29-34. 2015

Könönen Mervi, Danner Nils, Koskenkorva Päivi, Kälviäinen Reetta, Hyppönen Jelena, Mervaala Esa, Karjalainen Pasi, Vanninen Ritva, Niskanen Eini. 2015. Reduced cortical activation in inferior frontal junction in Unverricht-Lundborg disease (EPM1) - A motor fMRI study. EPILEPSY RESEARCH 111: 78-84. 2015

Könönen Mervi, Tamsi Niko, Säisänen Laura, Kemppainen Samuli, Määttä Sara, Julkunen Petro, Jutila Leena, Äikiä Marja, Kälviäinen Reetta, Niskanen Eini, Vanninen Ritva, Karjalainen Pasi, Mervaala Esa. 2015. Non-invasive mapping of bilateral motor speech areas using navigated transcranial magnetic stimulation and functional magnetic resonance imaging. JOURNAL OF NEUROSCIENCE METHODS 248: 32-40. 2015

Muraja-Murro Anu, Mervaala Esa, Westeren-Punnonen Susanna, Lepola Pasi, Töyräs Juha, Myllymaa Sami, Julkunen Petro, Kantanen Anne-Mari, Kälviäinen Reetta, Myllymaa Katja. 2015. Forehead EEG electrode set versus full-head scalp EEG in 100 patients with altered mental state. EPILEPSY & BEHAVIOR 49: 245-249. 2015

Tomson Torbjörn, Marson Anthony, Boon Paul, Canevini Maria Paola, Covanis Athanasios, Gaily Eija, Kälviäinen Reetta, Trinka Eugen. 2015. Valproate in the treatment of epilepsy in girls and women of childbearing potential. EPILEPSIA (NY) 56 7: 1006-10019. 2015

Rosenow F, Kelemen A, Ben-Menachem E, McShea C, Isojarvi J, Doty P on behalf of the SP774 study investigators (incl. Reetta Kälviäinen). 2015. Long-term adjunctive lacosamide treatment in patients with partial-onset seizures. ACTA NEUROLOGICA SCANDINAVICA 133 2 (February 2016): 136-144. 2015

Saavalainen Taavi, Jutila Leena, Mervaala Esa, Kälviäinen Reetta, Vanninen Ritva, Immonen Arto. 2015. Temporal anteroinferior encephalocele: An underrecognized etiology of temporal lobe epilepsy?. NEUROLOGY [epub ahead of print Sep 25, 2015]: -. 2015

Tomson Torbjörn, Battino Dina, Bonizzoni Erminio, Craig John, Lindhout Dick, Perucca Emilio, Sabers Anne, Thomas Sanjeev V, Vajda Frank for the EURAP Study Group (incl. Reetta Kälviäinen). 2015. Dose-dependent teratogenicity of valproate in mono- and polytherapy : An observational study. NEUROLOGY online before print June 17, 2015. 2015

Kälviäinen Reetta. 2015. Progressive Myoclonus Epilepsies. Seminars in Neurology 35 3: 293-299. 2015

Kälviäinen Reetta. 2015. Tiagabine. Teoksessa: Shorvon Simon D, Perucca Emilio, Engel Jerome Jr. (Eds.) (toim.) Treatment of Epilepsy (4th Edition). WILEY-BLACKWELL. s. 633-641. 2015

Kälviäinen Reetta. 2015. Intranasal therapies for acute seizures. EPILEPSY & BEHAVIOR 49: 303-306. 2015

Kivekäs Eija, Kinnunen Ulla-Mari, Haatainen Kaisa, Kälviäinen Reetta, Saranto Kaija. 2015. Trigger Development for the Improvement of Neurological Patient Care. Teoksessa: Indra Neil Sarkar, Andrew Georgiou, Paulo Mazzoncini de Azevedo Marques (toim.), MEDINFO 2015: eHealth-enabled Health. IOS Press. Studies in Health Technology and InformaticsY 216. s. 1116. 2015

Kimiskidis Vasilios K, Koutlis Christos, Tsimpiris Alkiviadis, Kälviäinen Reetta, Ryvlin Philippe, Kugiumtzis Dimitris. 2015. Transcranial Magnetic Stimulation Combined with EEG Reveals Covert States of Elevated Excitability in the Human Epileptic Brain. International Journal of Neural Systems 25 5: 20 pages. 2015

Kantanen Anne-Mari, Reinikainen Matti, Parviainen Ilkka, Ruokonen Esko, Ala-Peijari Marika, Bäcklund Tom, Koskenkari Juha, Laitio Ruut, Kälviäinen Reetta. 2015. Incidence and mortality of super-refractory status epilepticus in adults. EPILEPSY & BEHAVIOR 49: 131-134. 2015

Hyppönen Jelena, Äikiä Marja, Joensuu Tarja, Julkunen Petro, Danner Nils, Koskenkorva Päivi, Vanninen Ritva, Lehesjoki Anna-Elina, Mervaala Esa, Kälviäinen Reetta. 2015. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study. NEUROLOGY 84 15: 1529-1536. 2015

Huttunen Jukka, Kurki Mitja I, von und zu Fraunberg Mikael, Koivisto Timo, Ronkainen Antti, Rinne Jaakko, Jääskeläinen Juha E, Kälviäinen Reetta, Immonen Arto. 2015. Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study. NEUROLOGY 84 22: 2229-37. 2015

Ferlisi M, Hocker S, Grade M, Trinka E, Shorvon S on behalf of the International Steering Committee of the StEp Audit (incl. Reetta Kälviäinen). 2015. Preliminary results of the global audit of treatment of refractory status epilepticus. EPILEPSY & BEHAVIOR 49: 318-324. 2015

Bruun Emmi, Virta Lauri J, Kälviäinen Reetta, Keränen Tapani. 2015. Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: A Finnish retrospective study. SEIZURE 31: 27-32. 2015

Baulac Michel, de Boer Hanneke, Elger Christian, Glynn Mike, Kälviäinen Reetta, Little Ann, Mifsud Janet, Perucca Emilio, Pitkänen Asla, Ryvlin Philippe. 2015. Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force. EPILEPSIA (NY) [epub ahead of print 28 SEP 2015]: -. 2015

Kälviäinen Reetta, Genton Pierre, Andermann Eva, Andermann Frederick, Magaudda Adriana, Frucht Steven J, Schlit Anne-Françoise, Gerard Danielle, de la Loge Christine, von Rosenstiel Philipp. 2015. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies. EPILEPSIA (NY) 57 2 (2016): 210-221. 2015

Jutila Leena, Äikiä Marja, Immonen Arto, Mervaala Esa, Alafuzoff Irina, Kälviäinen Reetta. 2014. Long-term memory performance after surgical treatment of unilateral temporal lobe epilepsy (TLE). EPILEPSY RESEARCH 108 7: 1228-1237. 2014

Hynynen J, Komulainen T, Tukiainen E, Nordin A, Arola J, Kälviäinen R, Jutila L, Röyttä M, Hinttala R, Majamaa K, Mäkisalo H, Uusimaa J. 2014. Acute Liver Failure After Valproate Exposure in Patients With POLG1 Mutations and the Prognosis After Liver Transplantation. LIVER TRANSPLANTATION 20 11: 1402-1412. 2014

Anney RJ, Avbersek A, Balding D, Baum L, Becker F, Berkovic SF, Bradfield JP, Brody LC, Buono RJ, Catarino CB, Cavalleri GL, Cherny SS, Chinthapalli K, Coffey AJ, Compston A, Cossette P, de Haan G-H, De Jonghe P, de Kovel CGF, ..., Kälviäinen R, et al., International League Against Epilepsy Consortium on Complex Epilepsies ,. 2014. Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. LANCET NEUROLOGY 13: 893-903. 2014

Kimiskidis Vasilios K, Valentin Antionio, Kälviäinen Reetta. 2014. Transcranial magnetic stimulation for the diagnosis and treatment of epilepsy. CURRENT OPINION IN NEUROLOGY (PHILADELPHIA PA) 27 2: 236-241. 2014

Suoranta S, Holli-Helenius K, Koskenkorva P, Niskanen E, Könönen M, Aikiä M, Eskola H, Kälviäinen R, Vanninen R. 2013. 3D Texture Analysis Reveals Imperceptible MRI Textural Alterations in the Thalamus and Putamen in Progressive Myoclonic Epilepsy Type 1, EPM1. PLOS ONE [ONLINE] 8 7: e69905. 2013

Manninen O, Koskenkorva P, Lehtimäki KK, Hyppönen J, Könönen M, Laitinen T, Kalimo H, Kopra O, Kälviäinen R, Gröhn O, Lehesjoki AE, Vanninen R. 2013. White Matter Degeneration with Unverricht-Lundborg Progressive Myoclonus Epilepsy: A Translational Diffusion-Tensor Imaging Study in Patients and Cystatin B-Deficient Mice. RADIOLOGY 2013 Jun 20. [Epub ahead of print]: --. 2013

Räisänen S, Sokka A, Georgiadis L, Harju M, Gissler M, Keski-Nisula L, Kälviäinen R, Heinonen S. 2013. Infertility treatment and umbilical cord length-novel markers of childhood epilepsy?. PLOS ONE [ONLINE] 8 2: e55394. 2013

Kasperaviciute Dalia, Catarino Claudia B, Matarin Mar, Leu Costin, Novy Jan, Tostevin Anna, Leal Barbara, Hessel Ellen VS, Hallman Kerstin, Hildebrand Michael S, Dahl Hans-Henrik M, Ryten Mina, Trabzuni Daniah, Ramasamy Adaikalavan, Alhusaini Saud, Doherty Colin P, Dorn Thomas, Hansen Jörg, Krämer Gunter, Steinhoff Bernhard J, Zumsteg Dominik, Duncan Susan, Kälviäinen Reetta K et.al.. 2013. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. BRAIN Published online: 1-11. 2013

Julkunen P, Säisänen L, Könönen M, Vanninen R, Kälviäinen R, Mervaala E. 2013. TMS-EEG reveals impaired intracortical interactions and coherence in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1). EPILEPSY RESEARCH S0920-1211 13: 00103-4. 2013

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T. 2013. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. EPILEPSIA (NY) 54 3: 551-563. 2013

Danner N, Julkunen P, Hyppönen J, Niskanen E, Säisänen L, Könönen M, Koskenkorva P, Vanninen R, Kälviäinen R, Mervaala E. 2013. Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease. MOVEMENT DISORDERS (NEW YORK NY) 28 13: 1860-1867. 2013

Baulac M, De Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A. 2012. The Written Declaration on Epilepsy: An important achievement for Europe and beyond SEIZURE 21: 75-76. 2012

Koskenkorva P, Niskanen E, Hyppönen J, Könönen M, Mervaala E, Soininen H, Kälviäinen R, Vanninen R. 2012. Sensorimotor, visual, and auditory cortical atrophy in Unverricht-Lundborg Disease mapped with cortical thickness analysis AJNR. AMERICAN JOURNAL OF NEURORADIOLOGY 33: 878-883. 2012

Kälviäinen R, Dörfler A. 2012. Structural brain imaging. Teoksessa: Stefan H, Theodore WH (toim.), Handbook of Clinical Neurology. ss. 359-368. 2012

Niskanen E, Könönen M, Villberg V, Nissi M, Ranta-aho P, Säisänen L, Karjalainen P, Äikiä M, Kälviäinen R, Mervaala E, Vanninen R. 2012. The effect of fMRI task combinations on determining the hemispheric dominance of language functions. NEURORADIOLOGY 54: 393-405. 2012

Suoranta S, Manninen H, Koskenkorva P, Könönen M, Laitinen R, Lehesjoki AE, Kälviäinen R, Vanninen R. 2012. Thickened skull, scoliosis and other skeletal findings in Unverricht-Lundborg disease link cystatin B function to bone metabolism. BONE 51 6: 1016-1024. 2012

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke H-J, Smith PE, Pohlmann-Eden B. 2012. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY - 2012 Aug 29. [Epub ahead of print]: 1-10. 2012

Kwan P, Brodie MJ, Kälviäinen R, Yurkewicz L, Weaver J, Knapp LE. 2011. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. LANCET NEUROLOGY 10: 881-890. 2011

Walker SD, Kälviäinen R. 2011. Non-vision adverse events with vigabatrin therapy ACTA NEUROLOGICA SCANDINAVICA 124: 72-82. 2011

Danner N, Julkunen P, Könönen M, Hyppönen J, Koskenkorva P, Vanninen R, Lehesjoki A-E, Kälviäinen R, Mervaala E. 2011. Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1). SEIZURE 20: 65-71. 2011

Kupila L, Jutila L, Immonen A, Vanninen R, Mervaala E, Pateau A, Luostarinen L, Kälviäinen R. 2011. Late-onset Rasmussen's encephalitis and long-term remission EPILEPTIC DISORDERS 13 1: 88-91. 2011

Danner Nils, Säisänen Laura, Määttä Sara, Julkunen Petro, Hukkanen Taina, Könönen Mervi, Hyppönen Jelena, Kälviäinen Reetta, Mervaala Esa. 2011. Motor cortical plasticity is impaired in Unverrich-Lundborg disease. MOVEMENT DISORDERS (NEW YORK NY) 26 11: 2095-2100. 2011

Danner N, Säisänen L, Määttä S, Julkunen P, Hukkanen T, Könönen M, Hyppönen J, Kälviäinen R, Mervaala E. 2011. Motor cortical plasticity is impaired in Unverricht-Lundborg Disease. MOVEMENT DISORDERS (NEW YORK NY) 26: 2095-2100. 2011

Koskenkorva P, Hyppönen J, Aikiä M, Mervaala E, Kiviranta T, Eriksson K, Lehesjoki AE, Vanninen R, Kälviäinen R.. 2011. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene. NEURODEGENERATIVE DISEASES 8 6: 515-522. 2011

Musialowicz T, Mervaala E, Kälviäinen R, Uusaro A, Ruokonen E & Parviainen I. 2010. Can BIS monitoring be used to assess the depth of propofol anesthesia in the treatment of refractory status epilepticus?. EPILEPSIA (NY) 51 8: 1580-1586. 2010

Säisänen L, Könönen M, Julkunen P, Määttä S, Vanninen R, Immonen A, Jutila L, Kälviäinen R, Jääskeläinen JE & Mervaala E. 2010. Non-invasive preoperative localization of primary motor cortex in epilepsy surgery by navigated transcranial magnetic stimulation. EPILEPSY RESEARCH 92: 134-144. 2010

Sorri I, Brigell MG, Malyusz M, Mahlamäki E, de Meynard C & Kälviäinen R. 2010. Is reduced ornithine-gamma-aminotransferase activity the cause of vigabatrin-associated visual field defects? EPILEPSY RESEARCH 92: 48-53. 2010

Ryvlin P, Kälviäinen R, Von Raison F, Giordano S, Emir B & Chatamra K. 2010. Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS). EUROPEAN JOURNAL OF NEUROLOGY 17: 726-732. 2010

Sperling MR, Greenspan A, Cramer JA, Kwan P, Kälviäinen R, Halford JJ, Schmitt J, Yuen E et al. 2010. Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials. EPILEPSIA (NY) 51 3: 333-343. 2010

Kasperaviciute D, Catarino CB, Heinzen EL, Depondt C, Cavalleri GL, Caboclo LO, Tate SK, Jamnadas-Khoda J et al. 2010. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. BRAIN 133: 2136-2147. 2010

Immonen A, Jutila L, Muraja-MurroA, Mervaala E, Äikiä M, Lamusuo S, Kuikka J, Vanninen E, Alafuzoff I, Ikonen A, Vanninen R, Vapalahti M & Kälviäinen R. 2010. Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy. EPILEPSIA (NY) 51 11: 2260-2269. 2010

Heinzen EL, Radtke RA, Urban TJ, Cavalleri GL, Depondt C, Need AC, Walley NM, Nicoletti P, Ge D, Catarino CB et al. 2010. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. AMERICAN JOURNAL OF HUMAN GENETICS 86: 707-718. 2010

Eriksson K & Kälviäinen R. 2010. Long-term neurocognitive adverse effects of prenatal antiepileptic drug exposure. Expert Review of Clinical Pharmacology 3 1: 131-137. 2010

Hakonen AH, Isohanni P, Rantamäki M, Kälviäinen R, Nordin A, Uusimaa J, Paetau A, Udd B, Pihko H & Wartiovaara A. 2010. Mitokondriaalinen resessiivinen ataksiasyndrooma ja valproaattihoidon toksisuus. DUODECIM 126: 1552-1559. 2010

Kälviäinen R. 2009. Clinical trials in status epilepticus-The clinical perspective. EPILEPSIA. SUPPLEMENT 50: 75-76. 2009

Koskenkorva P, Khyuppenen J, Niskanen E, Könönen M, Bendel P, Mervaala E, Lehesjoki AE, Kälviäinen R, Vanninen R, Könönen M. 2009. Motor cortex and thalamic atrophy in Unverricht-Lundborg disease: Voxel-based morphometric study. NEUROLOGY 73: 606-611. 2009

Halász P, Kälviäinen R, Mazurkiewicz-Beldrinska M, Rosenow F, Doty P, Hebert D, Sullivan T, on behalf of the SP755 STUDY Group. 2009. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety from a randomized controlled trial. EPILEPSIA (NY) 50: 443-453. 2009

Eriksson K, Keränen T, Kälviäinen R. 2009. Fosphenytoin. EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY 5 6: 695-701. 2009

Danner N, Julkunen P, Khyuppenen J, Hukkanen T, Könönen M, Säisänen L, Koskenkorva P, Vanninen R, Lehesjoki AE, Kälviäinen R, Mervaala E, Könönen M. 2009. Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1). EPILEPSY RESEARCH 85: 81-88. 2009

O'Dushlaine CT, Dolan C, Weale ME, Stanton A, Croke DT, Kalviainen R, Eriksson K, Kantanen AM, Gibson RA, Hosford D, Sisodiya SM, Gill M, Corvin AP, Morris DW, Delanty N, Cavalleri GL. 2008. An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy an other complex diseases. EUROPEAN JOURNAL OF HUMAN GENETICS 16: 176-183. 2008

Suomalaisen Lääkäriseuran Duodecimin ja , Suomen Neurologinen Yhdistys ry:n asettama työryhmä, Kälviäinen R, Vapalahti M. 2008. Aikuisten epilepsiat DUODECIM 24: 2874-2888. 2008

Narkilahti S, Jutila L, Alafuzoff I, Karkola K, Paljärvi L, Immonen A, Vapalahti M, Mervaala E, Kälviäinen R, Pitkänen A. 2007. Increased expression of caspase 2 in experimental and human temporal lobe epilepsy NEUROMOLECULAR MEDICINE 9 2: 129-144. 2007

Viinikainen K, Heinonen S, Eriksson K, Kälviäinen R. 2007. Fertility in women with active epilepsy. NEUROLOGY 69: 2107-2108. 2007

Parviainen I, Kälviäinen R, Ruokonen E. 2007. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. NEUROLOGICAL RESEARCH 29 7: 667-671. 2007

Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, Szoeke C, Murphy K, Kinirons P, O'Rourke D, Ge D, Depondt C, Claeys KG, Pandolfo M, Gumbs C, Walley N, McNamara J, Mulley JC, Linney KN, Sheffield LJ, Radtke RA, Tate SK, Chissoe ST, Gibson RA, Hosford D, Stanton A, Graves TD, Hanna MG, Eriksson K, Kantanen A-M, Kalviainen R, ...... 2007. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case control-study. LANCET NEUROLOGY 6: 970-980. 2007

Kälviäinen R. 2007. Status epilepticus treatment guidelines. EPILEPSIA. SUPPLEMENT 48 8: 99-102. 2007

Kälviäinen R, Eriksson K, Losekoot M, Sorri I, Harvima I, Santavuori P, Järvelä I, Autti T, Vanninen R, Salmenperä T, van Diggelen OP. 2007. Juvenile-onset neuronal ceroid lipofuscinosis with infantile CNL1 mutation and palmitoyl-protein thioesterase deficiency. EUROPEAN JOURNAL OF NEUROLOGY 14: 369-372. 2007

Koponen A, Seppälä U, Eriksson K, Nieminen P, Uutela A, Sillanpää M, Hyvärinen L, Kälviäinen R. 2007. Social functioning and psychological well-being of 347 young adults with epilpsy only-population-based, controlled study from Finland EPILEPSIA (NY) 48 5: 907-912. 2007

Herrgård E, Mononen T, Mervaala E, Kuusela L, Äikiä M, Stenbäck U, Pääkkönen L, Airaksinen R-L, Kälviäinen R. 2007. More severe epilepsy and cognitive impairment in the offspring of a mother with mosaicism for the ring 20 chromosome EPILEPSY RESEARCH 73 1: 122-128. 2007

Äikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R. 2006. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. EPILEPSY & BEHAVIOR 8 4: 750-755. 2006

Äikiä M, Jutila L, Salmenperä T, Mervaala E, Kälviäinen R. 2006. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies EPILEPSIA (NY) 47 7: 1121-1127. 2006

Viinikainen K, Heinonen S, Eriksson K, Kälviäinen R. 2006. Community-based, prostective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. EPILEPSIA (NY) 47 1: 186-192. 2006

Viinikainen K, Eriksson K, Mönkkönen A, Äikiä M, Nieminen P, Heinonen S, Kälviäinen R. 2006. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children EPILEPSY & BEHAVIOR 9: 636-640. 2006

Sillanpää M, Kälviäinen R, Klaukka T, Helenius H, Shinnar S. 2006. Temporal changes in the incidence of epilepsy in Finland: nationwide study. EPILEPSY RESEARCH 71: 206-215. 2006

Parviainen I, Uusaro A, Kälviäinen R, Mervaala E, Ruokonen E. 2006. Propofol in the treatment of refractory status epilepticus. INTENSIVE CARE MEDICINE 32: 1075-1079. 2006

Kälviäinen R, Tomson T. 2006. Optimizing treatment of epilepsy during pregnancy. NEUROLOGY. SUPPLEMENT 67 4: S59-S63. 2006

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. 2006. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes EPILEPSIA (NY) 47 7: 1094-1120. 2006

Pirttilä TJ, Manninen A, Jutila L, Nissinen J, Kälviäinen R, Vapalahti M, Immonen A, Paljärvi L, Karkola K, Alafuzoff I, Mervaala E, Pitkänen A. 2005. Cystatin C expression is associated with granule cell dispersion in epilepsy. ANNALS OF NEUROLOGY 58 2: 211-223. 2005

Sorri I, Rissanen E, Mäntyjärvi M, Kälviäinen R. 2005. Visual function in epilepsy patients treated with initial valproate monotherapy SEIZURE 14: 367-370. 2005

Sorri I, Kälviäinen R, Mäntyjärvi M. 2005. Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy. EPILEPSY RESEARCH 67 3: 101-107. 2005

Sorri I, Herrgård E, Viinikainen K, Pääkkönen A, Heinonen S, Kälviäinen R. 2005. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero EPILEPSY RESEARCH 65: 117-120. 2005

Salmenperä T, Könönen M, Roberts N, Vanninen R, Pitkänen A, Kälviäinen R, Könönen M. 2005. Hippocampal damage in newly diagnosed focal epilepsy: a prospective MRI study. NEUROLOGY 64: 62-68. 2005

Zhang Z, Berg M, Ikonen A, Könönen M, Kälviäinen R, Manninen H, Vanninen R, Könönen M. 2005. Carotid stenosis degree in CT angiography: assessment based on luminal area versus luminal diameter measurements. EUROPEAN RADIOLOGY 15: 2359-2365. 2005

Kälviäinen R. 2005. Status epilepticuksen hoito - ennusteeseen voidaan vaikuttaa tehokkaalla varhaisella hoidolla ERIKOISLÄÄKÄRI 15 6: 239-242. 2005

Goncalves Pereira PM, Insausti R, Artacho-Pérula E, Salmenperä T, Kälviäinen R, Pitkänen A. 2005. MR volumetric analysis of the piriform cortex and cortical amygdala in drug-refractory temporal lobe epilepsy. AJNR. AMERICAN JOURNAL OF NEURORADIOLOGY 26: 319-332. 2005

Eriksson K, Viinikainen K, Mönkkönen A, Äikiä M, Nieminen P, Heinonen S, Kälviäinen R. 2005. Children exposed to valproate in utero-Population based evaluation of risks and confounding factors for long-term neurocognitive development EPILEPSY RESEARCH 65: 189-200. 2005

Eriksson K, Peltola J, Kälviäinen R. 2005. Kohtausten hoidosta epilepsian hoitoon - tunnista epilepsiaoireyhtymä DUODECIM 121: 505-512. 2005

Eriksson K, Kälviäinen R. 2005. Pharmacologic management of convulsive status epilepticus in childhood. EXPERT REVIEW OF NEUROTHERAPEUTICS 5 6: 777-783. 2005

Berg M, Zhang Z, Ikonen A, Sipola P, Kälviäinen R, Manninen H, Vanninen R. 2005. Multi-detector row CT angiography in the assessment of carotid artery disease in the symtomatic patients: comparison with rotaional angiography and digital subtraction angiography. AJNR. AMERICAN JOURNAL OF NEURORADIOLOGY 26: 1022-1034. 2005

Kälviäinen R, Eriksson K, Parviainen I. 2005. Refractory generalised convulsive status epilepticus - A guide to treatment. CNS DRUGS 19 9: 759-768. 2005

Immonen A, Jutila L, Kälviäinen R, Mervaala E, Partanen K, Partanen J, Vanninen R, Ylinen A, Alafuzoff I, Paljärvi L, Hurskainen H, Rinne J, Puranen M, Vapalahti M. 2004. Preoperative clinical evaluation, outline of surgical technique and outcome in termporal lobe epilepsy ADVANCES AND TECHNICAL STANDARDS IN NEUROSURGERY 29: 87-132. 2004

Kälviäinen R. 2003. A woman with seven monotherapies EPILEPSY & BEHAVIOR. SUPPLEMENT 4: S8-S11. 2003

Kälviäinen R. 2002. Temporal lobe resection in a patient with severe psychiatric problems: Schmidt D, Schachter SC, 110 Puzzling Cases of Epilepsy.Martin Dunitz. 395-397. 2002

Parviainen I, Uusaro A, Kälviäinen R, Kaukanen E, Mervaala E, Ruokonen E. 2002. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit NEUROLOGY 59: 1249-1251. 2002

Jutila L, Immonen A, Mervaala E, Partanen J, Partanen K, Puranen M, Kälviäinen R, Alafuzoff I, Hurskainen H, Vapalahti M, Ylinen A. 2002. Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 73: 486-494. 2002

Kälviäinen R, Salmenperä T. 2002. Do recurrent seizures cause neuronal damage? A series of studies with MRI volumetry in adults with partial epilepsy: Sutula T, Pitkänen A, Do Seizures Damage the Brain.Elsevier. Progress in Brain Research. 279-295. 2002

Äikiä M, Salmenperä T, Partanen K, Kälviäinen R. 2001. Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy. EPILEPSY & BEHAVIOR 2: 20-27. 2001

Schmidt D, Arroyo S, Baulac M, Dam M, Dulac O, Friis ML, Kälviäinen R, Krämer G, van Parys J, Pedersen B, Sachdeo R. 2001. Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view. ACTA NEUROLOGICA SCANDINAVICA 104: 167-170. 2001

Salmenperä T, Kälviäinen R, Partanen K, Pitkänen A. 2001. Hippocampal and amygdaloid damage in partial epilepsy A cross-sectional MRI study of 241 patients. EPILEPSY RESEARCH 46: 69-82. 2001

Ojala M, Kälviäinen R. 2001. Insurability of patients with epilepsy: perspectives of physicians and insurance companies. Teoksessa: Johannessen SI, Tomson T, Sillanpää M, Pedersen B (toim.), Medical Risks in Epilepsy.Wrightson Biomedical Publishing. ss. 139-140. 2001

Ojala M, Hyvärinen L, Juntunen J, Keränen T, Kälviäinen R, Mûller K, Wallin A. 2001. Epilepsia ja ajokyvyn arviointi - suomalainen menettelyohje. SUOMEN LÄÄKÄRILEHTI 56 49-50: 5121-5123. 2001

Nousiainen I, Mäntyjärvi M, Kälviäinen R. 2001. No reversion in vigabatrin-associated visual field defects. NEUROLOGY 57: 1916-1917. 2001

Lamusuo S, Jutila L, Ylinen A, Kälviäinen R, Mervaala E, Haaparanta M, Jääskeläinen S, Partanen K, Vapalahti M, Rinne J. 2001. [18F] FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage ARCHIVES OF NEUROLOGY 58: 933-939. 2001

Kälviäinen R, Äikiä M. 2001. Kognitiiviset häiriöt neurologisissa sairauksissa. Epilepsia: Erkinjuntti T, Rinne J, Alhainen K, Soininen H, Muistihäiriöt ja dementia.Duodecim. 274-278. 2001

Kälviäinen R. 2001. Monotherapy trial design: conversion versus de novo. EPILEPSY RESEARCH 45: 75-78. 2001

Kälviäinen R. 2001. Long-term safety of tiagabine. EPILEPSIA. SUPPLEMENT 42 3: 46-48. 2001

Kälviäinen R, Nousiainen I. 2001. Visual field defects with vigabatrin. Epidemiology and therapeutic implications CNS DRUGS 15 3: 217-230. 2001

Salmenperä T, Kälviäinen R, Partanen K, Pitkänen A. 2000. Quantitative MRI volumetry of the entorhinal cortex in temporal lobe epilepsy. SEIZURE 9: 208-215. 2000

Schmidt D, Gram L, Brodie M, Krämer G, Perucca E, Kälviäinen R, Elger CE. 2000. Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescibing physician. EPILEPSY RESEARCH 41: 245-251. 2000

Nousiainen I, Kälviäinen R, Mäntyjärvi M. 2000. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy OPHTHALMOLOGY 107: 884-888. 2000

Salmenperä T, Kälviäinen R, Partanen K, Mervaala E, Pitkänen A. 2000. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus. EPILEPSY RESEARCH 40: 155-170. 2000

Nousiainen I, Mäntyjärvi M, Kälviäinen R. 2000. Visual function in patients with the GABAergic anticonvulsant drug tiagabine CLINICAL DRUG INVESTIGATION 20 6: 393-400. 2000

Nousiainen I, Kälviäinen R, Mäntyjärvi M. 2000. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers BRITISH JOURNAL OF OPHTHALMOLOGY 84: 622-625. 2000

Chadwick D, for the Vigabatrin European Monotherapy Study Group, Kälviäinen R. 1999. Safety and efficscy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study LANCET 354: 13-19. 1999

Kälviäinen R, Nousiainen I, Mäntyjärvi M, Nikoskelainen E, Partanen J, Partanen K, Riekkinen P Sr. 1999. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. NEUROLOGY 53: 922-926. 1999

Kälviäinen R, Pitkänen A. 1999. Prevention of seizure-induced neuronal damage and intellectual deterioration: experimental aspects and clinical implications. Teoksessa: Sillanpää M, Gram L, Johannessen SI, Tomson T (toim.), Epilepsy and Mental Retardation.Wrightson Biomedical Publishing . ss. 165 - 178. 1999

Kälviäinen R. 1999. Cognitive effects of GABAergic antiepileptic drugs. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY. SUPPLEMENT 50: 458-464. 1999

Pitkänen A, Salmenperä T, Äikiä M, Partanen K, Kälviäinen R. 1999. Seizure-induced damage to the medial temporal lobe in temporal lobe epilepsy: Sillanpää M, Gram L, Johannessen SI, Tomson T, Epilepsy and Mental Retardation.Wrightson Biomedical Publishing . 147-163. 1999

Äikiä M, Kälviäinen R, Mervaala E, Riekkinen PJ Sr. 1999. Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor. EPILEPSY RESEARCH 37: 159-167. 1999

Kälviäinen R, Salmenperä T, Partanen K, Vainio P, Riekkinen P Sr, Pitkänen A. 1998. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. NEUROLOGY 50: 1377-1382. 1998

Mikkonen M, Soininen H, Kälviäinen R, Tapiola T, Ylinen A, Vapalahti M, Paljärvi L, Pitkänen A. 1998. Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex. ANNALS OF NEUROLOGY 44: 923-934. 1998

Pitkänen A, Tuunanen J, Kälviäinen R, Partanen K, Salmenperä T. 1998. Amygdala damage in experimental and human temporal lobe epilepsy. EPILEPSY RESEARCH 32: 233-253. 1998

Salmenperä T, Kälviäinen R, Partanen K, Pitkänen A. 1998. Hippocampal damage caused by seizures in temporal lobe epilepsy LANCET 351: 35. 1998

Lamusuo S, Ruottinen HM, Knuuti J, Härkönen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Rinne JK, Vapalahti M, Rinne JO. 1997. Comparison of (18F) FDG-PET, (99mTc)-HMPAO-SPECT, and (123)-iomazenil-SPECT in localising the epileptogenic cortex. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 63: 743-748. 1997

Kälviäinen R, Salmenperä T, Partanen K, Vainio P, Riekkinen P Sr, Pitkänen A. 1997. MRI volumetry and T2 relaxometry of the amygdala in newly diagnosed and chronic temporal lobe epilepsy. EPILEPSY RESEARCH 28: 39-50. 1997

Lafreniére RG, Rochefort DL, Chrétien N, Rommens JM, Cochius JI, Kälviäinen R, Nousiainen U, Patry G, Farrell K, Söderfeldt B, Federico A, Hale BR, Cossio OH, Sorensen T, Pouliot MA, Kmiec T, Uldall P, Janszky J, Pranzatelli MR, Anderman F, Anderman. 1997. Unstable insertion in the 5`flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. NATURE GENETICS 15: 298-302. 1997

Kälviäinen R, Partanen K, Äikiä M, Mervaala E, Vainio P, Riekkinen PJ Sr, Pitkänen A. 1997. MRI-based hippocampal volumetry and T2 relaxometry: correlation to verbal memory performance in newly diagnosed epilepsy patients with left-sided temporal lobe focus. NEUROLOGY 48: 286-287. 1997

Kälviäinen R, Riekkinen PJ Sr. 1996. In reply (to Vigabatrin and carbamazepine monotherapy for newly diagnosed epilepsy). ARCHIVES OF NEUROLOGY 53: 478. 1996

Kälviäinen R, Äikiä M, Mervaala E, Saukkonen AM, Pitkänen A, Riekkinen PJ Sr. 1996. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. EPILEPSY RESEARCH 25: 291-297. 1996

Kälviäinen R, Äikiä M, Riekkinen PJ Sr. 1996. Cognitive adverse effects of antiepileptic drugs. Incidence, mechanisms and therapeutic implications. CNS DRUGS 5 5: 358-368. 1996

Pitkänen A, Laakso M, Kälviäinen R, Partanen K, Vainio P, Lehtovirta M, Riekkinen P Sr, Soininen H. 1996. Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease NEUROLOGY 46: 1724-1730. 1996

Salmenperä T, Kälviäinen R, Ylinen A, Riekkinen PJ Sr. 1996. Cost of epilepsy: review of the literature. NEUROLOGIST 2: 230-238. 1996

Kälviäinen R, Mervaala E, Sivenius J, Riekkinen PJ Sr. 1995. Vigabatrin. Clinical use: Levy RH, Mattson RH, Meldrum BS, Antiepileptic Drugs, Fourth Edition.Raven Press. 925-930. 1995

Kälviäinen R, Riekkinen PJ Sr. 1995. New anti-epileptic drugs. EXPERT OPINION ON INVESTIGATION DRUGS 4 10: 955-962. 1995

Kälviäinen R, Äikiä M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. 1995. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy ARCHIVES OF NEUROLOGY 52: 989-996. 1995

Ylinen A, Kälviäinen R, Riekkinen PJ Sr. 1995. Long-term efficacy and cognitive effects of vigabatrin ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM 162: 47-50. 1995

Äikiä M, Kälviäinen R, Riekkinen PJ. 1995. Verbal learning and memory in newly diagnosed partial epilepsy. EPILEPSY RESEARCH 22: 157-164. 1995

Cochius J, Carpenter S, Andermann E, Rouleau G, Nousiainen U, Kälviäinen R, Farrell K, Andermann F. 1994. Sweat gland vacuoles in Unverricht-Lundborg disease: A clue to diagnosis? NEUROLOGY 44: 2372-2375. 1994

Saukkonen AM, Kälviäinen R, Partanen K, Vainio P, Riekkinen P, Pitkänen A. 1994. Do seizures cause neuronal damage? A MRI study in newly diagnosed and chronic epilepsy. NEUROREPORT 6: 219-223. 1994

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

Avainsanat

Julkaisut

Linkit

Tutkimusryhmät